Results 41 to 50 of about 181,956,994 (291)

American Society of Clinical Oncology 2014: Updates in breast and gastrointestinal cancers

Indian Journal of Medical and Paediatric Oncology, 2014
The last two decades have been very exciting in the realm of breast and GI oncology with a plethora of new information that has significantly impacted clinical practice.
Shaheenah Dawood
doaj   +1 more source

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review [PDF]

, 2018
Purpose.—Clinical use of analytical tests to assess genomic variants in circulating tumor DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology and the College of American Pathologists summarizes current information ...
Merker, JD, Hayes, DF, Patricia Vasalos, Maximilian Diehn, Richard L. Schilsky, Nicholas C. Turner, Oxnard, GR, Apostolia M. Tsimberidou, Suanna S. Bruinooge, Daniel F. Hayes, Alex J. Rai, Hurley, P, Brooke L. Billman, Schilsky, RL, Neal Lindeman, Geoffrey R. Oxnard, Alexander J. Lazar, Patricia Hurley, Jason D. Merker, Lazar, AJ, Diehn, M, Lockwood, CM, Bruinooge, SS, Thomas K. Oliver, Lindeman, N, Billman, BL, Compton, C, Turner, NC, Oliver, TK, Rai, AJ, Tsimberidou, AM, Christina M. Lockwood, Carolyn Compton, Vasalos, P   +33 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga, Anne B. Verbeek, Caroline A. Lindemans, Emilie P. Buddingh   +3 more
wiley   +1 more source

Feeding, Fear, and Acceptance: Caregivers’ Experiences of Nutritional Support During Childhood Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose To explore caregivers' experiences and perceptions of the nutritional challenges faced by children and adolescents undergoing cancer treatment, including oral intake and the use of nutritional support. Methods This was a qualitative study based on focus groups with parents and caregivers at a Brazilian pediatric oncology hospital ...
Danyelle Apparecida Balsamão Marques, Mariana dos Santos Murra, Welinton Hirai, Ana Laura Balduino do Nascimento, Karla Emilia de Sá Rodrigues, Wilson Elias de Oliveira Junior   +5 more
wiley   +1 more source

American Society of Clinical Oncology [PDF]

International Journal of Pharmaceutical Medicine, 2005
  +5 more sources

American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Safety Standards

Journal of Oncology Practice, 2013
Oncology nurses have used chemotherapy standards to develop educational materials and guidelines for standardization and safety and anticipate future opportunities to partner in translating evidence into practice.
openaire   +3 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

ASCO GI 2008

Onkologija, 2008
Ni abstrakta.
Vaneja Velenik
doaj  

Recomendaciones para cirugía en pacientes con patologías oncológicas durante la pandemia COVID-19

Revista Colombiana de Cirugía, 2020
Para emitir las recomendaciones específicas frente a la población de pacientes con cáncer, se tomaron en cuenta diversas observaciones en pacientes con patologías oncológicas en momentos de COVID-19, que muestran riesgo mayor de complicaciones en esta ...
Maikel Adolfo Pacheco Trujillo, Pilar Adriana Torres Mesa, Fernando Arias Amezquita, Pinilla Morales Raúl Eduardo, Abadia Diaz Mario Arturo , Ricardo Villarreal, Gómez Alferez Gómez Alferez , Giovanny Bonilla Ardila , Gilbert Gilbert López, Lilian Torregrosa Almonacid, Francisco Henao Pérez, Óscar Alexander Guevara, Alejandro Múnera-Duque, Juan Pablo Villate Juan Pablo Villate, Nelson Niño, Carlos Millán   +15 more
doaj   +1 more source